Losing significant amounts of weight may soon be as easy as taking a daily pill. New research shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes. Drugmaker Novo Nordisk said it intends to seek approval for a weight-loss pill in the U.S. later this year.
Losing significant amounts of weight may soon be as easy as taking a daily pill. New research shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes. Drugmaker Novo Nordisk said it intends to seek approval for a weight-loss pill in the U.S. later this year.
Losing significant amounts of weight may soon be as easy as taking a daily pill. New research shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes. Drugmaker Novo Nordisk said it intends to seek approval for a weight-loss pill in the U.S. later this year.
Losing significant amounts of weight may soon be as easy as taking a daily pill. New research shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes. Drugmaker Novo Nordisk said it intends to seek approval for a weight-loss pill in the U.S. later this year.
Losing significant amounts of weight may soon be as easy as taking a daily pill. New research shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes. Drugmaker Novo Nordisk said it intends to seek approval for a weight-loss pill in the U.S. later this year.